{
    "clinical_study": {
        "@rank": "87606", 
        "brief_summary": {
            "textblock": "RATIONALE: Cryosurgery kills cancer cells by freezing them. Cryosurgery followed by\n      lumpectomy or mastectomy may be an effective treatment for breast lesions.\n\n      PURPOSE: Phase I trial to study the effectiveness of cryosurgery in treating women who have\n      breast lesions."
        }, 
        "brief_title": "Cryosurgery in Treating Women With Breast Lesions", 
        "completion_date": {
            "#text": "July 2004", 
            "@type": "Actual"
        }, 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Determine the feasibility of temperature-monitored, ultrasound-guided cryosurgery in\n           women with highly suspicious breast lesions.\n\n        -  Determine the safety of this procedure in these patients.\n\n      OUTLINE: This is a multicenter study.\n\n      Patients undergo cryoablation of up to two breast lesions. Within 3-21 days, patients\n      undergo lumpectomy or mastectomy.\n\n      Patients are followed at 1, 4, 8, and 12 weeks after lumpectomy or mastectomy.\n\n      PROJECTED ACCRUAL: A maximum of 25 patients will be accrued for this study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Highly suspicious breast lesion on prior mammogram and/or ultrasound with\n             confirmation of malignancy on ultrasound-guided core biopsy\n\n               -  Tumor no greater than 2.0 cm in diameter\n\n          -  Eligible for lumpectomy or mastectomy\n\n          -  No superficial breast lesions\n\n          -  No prior open surgical biopsy\n\n          -  Hormone receptor status:\n\n               -  Not specified\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  Any age\n\n        Sex:\n\n          -  Female\n\n        Menopausal status:\n\n          -  Not specified\n\n        Performance status:\n\n          -  Not specified\n\n        Life expectancy:\n\n          -  Not specified\n\n        Hematopoietic:\n\n          -  Not specified\n\n        Hepatic:\n\n          -  Not specified\n\n        Renal:\n\n          -  Not specified\n\n        Other:\n\n          -  No other illness that would preclude study participation\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  Not specified\n\n        Chemotherapy:\n\n          -  Not specified\n\n        Endocrine therapy:\n\n          -  Not specified\n\n        Radiotherapy:\n\n          -  Not specified\n\n        Surgery:\n\n          -  See Disease Characteristics\n\n          -  No other surgery that would preclude study participation\n\n        Other:\n\n          -  No other medical treatment that would preclude study participation"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "firstreceived_date": "July 11, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00020852", 
            "org_study_id": "UCLA-9908076", 
            "secondary_id": [
                "CDR0000068724", 
                "NCI-G01-1964"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "conventional surgery", 
                "intervention_type": "Procedure"
            }, 
            {
                "intervention_name": "cryosurgery", 
                "intervention_type": "Procedure"
            }
        ], 
        "keyword": [
            "stage I breast cancer", 
            "stage II breast cancer"
        ], 
        "lastchanged_date": "May 29, 2013", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/UCLA-9908076"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Los Angeles", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "90095-7028"
                }, 
                "name": "Jonsson Comprehensive Cancer Center, UCLA"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Evaluation of Freezing Tumors in the Treatment of Breast Cancer Safety Study - 1-Probe CRYOcare Surgical System for Breast Tumor Ablation", 
        "overall_official": {
            "affiliation": "Jonsson Comprehensive Cancer Center", 
            "last_name": "Helena R. Chang, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 1", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00020852"
        }, 
        "source": "National Cancer Institute (NCI)", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Jonsson Comprehensive Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2001", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2004"
    }, 
    "geocoordinates": {
        "Jonsson Comprehensive Cancer Center, UCLA": "34.052 -118.244"
    }
}